Identification of new molecular markers for multiple myeloma paves path for more precise therapies

Researchers astatine Cima and Clinica Universidad de Navarra person identified caller molecular mechanisms underlying aggregate myeloma. This benignant of hematologic cancer, which affects the bony marrow, is characterized by its absorption to treatment, starring to relapses successful patients. The researchers' insubstantial is published successful the diary Blood.